Nessn H Azawi1,2, Kasper Drimer Berg3,4, Andreas Key Milan Thamsborg3, Claus Dahl3, Jan Viberg Jepsen5, Bjarne Kroman-Andersen5, Johan Poulsen6, Helle Handler Petersen6, L Henning Olsen7, Jørgen Bjerggaard Jensen7. 1. Department of Urology, Zealand University Hospital, Sygehusvej 10, 4000, Roskilde, Denmark. azawinessn@gmail.com. 2. Institute of Clinical Research, University of Southern Denmark, Odense M, Denmark. azawinessn@gmail.com. 3. Department of Urology, Zealand University Hospital, Sygehusvej 10, 4000, Roskilde, Denmark. 4. Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 5. Herlev and Gentofte University Hospital, Herlev, Denmark. 6. Aalborg University Hospital, Aalborg, Denmark. 7. Aarhus University Hospital, Aarhus, Denmark.
Abstract
PURPOSE: To evaluate the effect of lymphadenectomy (LND) in conjunction with nephroureterectomy on cancer-specific mortality (CSM) and overall survival (OS) for patients with muscle-invasive UTUC. METHODS: A retrospective, multicenter study of patients with UTUC, clinical stage N0M0, who underwent nephroureterectomy between January 2008 and December 2014 was conducted. Outcome measures were OS and CSM. RESULTS: In total, 298 patients underwent robot-assisted or laparoscopic radical nephroureterectomy with a final histological diagnosis of UTUC. LND was performed in 46 (15.4%). One hundred and seventy-two patients (62%) had non-muscle-invasive disease (NMID); 105 patients (38%) had muscle-invasive disease (MID). Median time of follow-up was 43.5 months (95% CI 36.0-47.2). For patients with MID, the 5-year cumulative incidence of all-cause mortality and CSM was 73.5% (95% CI 60.4-86.6) and 52.4% (95% CI 38.9-65.9), respectively (p < 0.0001). There was no significant difference in OS between patients with N1 and patients with N0 disease (p = 0.53). The 5-year OS rates were 30.5% (95% CI 6.6-54.4) and 25.7% (95% CI 10.9-40.5), respectively. This study is limited by its retrospective nature. There may also have been bias in the selection of patients undergoing LND. CONCLUSIONS: Five-year OS and CSM are comparable between patients with N1 and N0 MID. This evidence may support the use of the LND procedure in patients with muscle-invasive UTUC.
PURPOSE: To evaluate the effect of lymphadenectomy (LND) in conjunction with nephroureterectomy on cancer-specific mortality (CSM) and overall survival (OS) for patients with muscle-invasive UTUC. METHODS: A retrospective, multicenter study of patients with UTUC, clinical stage N0M0, who underwent nephroureterectomy between January 2008 and December 2014 was conducted. Outcome measures were OS and CSM. RESULTS: In total, 298 patients underwent robot-assisted or laparoscopic radical nephroureterectomy with a final histological diagnosis of UTUC. LND was performed in 46 (15.4%). One hundred and seventy-two patients (62%) had non-muscle-invasive disease (NMID); 105 patients (38%) had muscle-invasive disease (MID). Median time of follow-up was 43.5 months (95% CI 36.0-47.2). For patients with MID, the 5-year cumulative incidence of all-cause mortality and CSM was 73.5% (95% CI 60.4-86.6) and 52.4% (95% CI 38.9-65.9), respectively (p < 0.0001). There was no significant difference in OS between patients with N1 and patients with N0 disease (p = 0.53). The 5-year OS rates were 30.5% (95% CI 6.6-54.4) and 25.7% (95% CI 10.9-40.5), respectively. This study is limited by its retrospective nature. There may also have been bias in the selection of patients undergoing LND. CONCLUSIONS: Five-year OS and CSM are comparable between patients with N1 and N0 MID. This evidence may support the use of the LND procedure in patients with muscle-invasive UTUC.
Authors: J P Stein; G Lieskovsky; R Cote; S Groshen; A C Feng; S Boyd; E Skinner; B Bochner; D Thangathurai; M Mikhail; D Raghavan; D G Skinner Journal: J Clin Oncol Date: 2001-02-01 Impact factor: 44.544
Authors: Surena F Matin; Vitaly Margulis; Ashish Kamat; Christopher G Wood; H Barton Grossman; Gordon A Brown; Colin P N Dinney; Randall Millikan; Arlene O Siefker-Radtke Journal: Cancer Date: 2010-07-01 Impact factor: 6.860
Authors: Francesco Soria; Shahrokh F Shariat; Seth P Lerner; Hans-Martin Fritsche; Michael Rink; Wassim Kassouf; Philippe E Spiess; Yair Lotan; Dingwei Ye; Mario I Fernández; Eiji Kikuchi; Daher C Chade; Marko Babjuk; Arthur P Grollman; George N Thalmann Journal: World J Urol Date: 2016-09-07 Impact factor: 4.226
Authors: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Maxine Sun; Daniel Pharand; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz Journal: Urology Date: 2009-10-28 Impact factor: 2.649
Authors: Nivedita Bhatta Dhar; Eric A Klein; Alwyn M Reuther; George N Thalmann; Stephan Madersbacher; Urs E Studer Journal: J Urol Date: 2008-01-25 Impact factor: 7.450